Coronary angioplasty aka PCI is a common procedure with excellent success rates. The in-hospital mortality following PCI is 1-2% and in the setting of acute coronary syndrome is 3%. Additionally,1-2% of patients die after discharge within 30 days. Two recent retrospective database analyses from the states of New York and Michigan Blue shield studied mortality after PCI1,2. The New York database included 135,000 patients studying in-hospital and 30-day mortality while the Michigan database had 92,000 patients analysing in-hospital mortality. I present these papers with the learning points so that we can improve patient outcomes. The findings Both databases showed a 1.5% - 30-day mortality after PCI. 30% of these deaths are preventable. Most in-hospital deaths were non preventable (70%). They were attributed to pre-existing cardiac conditions such as cardiogenic shock, left ventricular failure, co-morbidities etc. Most of them are emergency and high-risk patients. 30% of in-hospital
Mitral Valve is the one which is tucked between the upper left atrium and lower left ventricle and when it gets narrowed, this becomes a major heart health issue which is called Mitral Valve Stenosis . Under this condition, the blood flow from the left atrium to the left ventricle is restricted and the blood starts to flow back into the left atrium, blood vessels of the lungs and to the right side of the heart too. Though stenosis occurs, symptoms don’t appear for a major part of one’s life, say 8 to 10 years. But in India, research suggests that the progression is quicker than in the rest of the world and symptoms surface within 8 to 10 years. As for the severity, such can be mild or severe. What are the possible reasons for mitral valve stenosis that we know? Rheumatic fever can be a discrepancy due to streptococcus infection. Calcium reserves due to old age. The congenital shortcoming in the mitral valve. Autoimmune diseases like lupus, can also contribute to this. Radiation th